Gene: CFAP126
Official Full Name: cilia and flagella associated protein 126provided by HGNC
Gene Summary: Predicted to be involved in cilium organization and flagellated sperm motility. Located in axonemal microtubule. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21005 | CFAP126 Knockout cell line (HCT 116) | Human | CFAP126 | 1:2~1:4 | Negative | Online Inquiry |
KO21006 | CFAP126 Knockout cell line (HEK293) | Human | CFAP126 | 1:3~1:6 | Negative | Online Inquiry |
KO21007 | CFAP126 Knockout cell line (A549) | Human | CFAP126 | 1:3~1:4 | Negative | Online Inquiry |
CFAP126 Gene Knockout Cell Lines are genetically engineered cell lines designed to specifically disrupt the CFAP126 (Cilia and Flagella Associated Protein 126) gene. This innovative product serves as a powerful tool for researchers investigating the physiological and pathological roles of CFAP126, which is implicated in a variety of ciliopathies and other diseases related to ciliary dysfunction. By utilizing CRISPR-Cas9 technology, these knockout cell lines allow scientists to precisely edit the genome, providing a clean and efficient method for studying gene function through loss-of-function experiments.
The key mechanism of action involves the targeted cleavage and subsequent deletion of the CFAP126 gene, leading to a complete absence of the CFAP126 protein. This genetic modification enables researchers to observe phenotypic changes and molecular pathways influenced by the absence of CFAP126, thus elucidating its role in ciliary structure and function. Given the significance of cilia in cellular signaling, motility, and development, these cell lines are invaluable for understanding diseases related to ciliary malformations.
In research settings, CFAP126 Gene Knockout Cell Lines can be leveraged to explore the genetic underpinnings of diverse human disorders, offering insights that may guide therapeutic strategies and interventions. Clinically, these cell lines have the potential to contribute to precision medicine approaches, particularly in conditions associated with impaired ciliary function.
What sets these knockout cell lines apart from alternative products is their specificity, reliability, and the comprehensive support provided with their usage. These cell lines come with validated backgrounds and extensive documentation, ensuring researchers have all the necessary tools to obtain reproducible and meaningful data.
For researchers and clinicians aiming to delve deeper into the complexities of genetic interactions and their implications in human health, CFAP126 Gene Knockout Cell Lines represent an indispensable resource. Leveraging years of expertise in genetic reagents and cell culture technologies, our company is committed to equipping the scientific community with high-quality products that advance research and foster innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.